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Ca2calmodulin-dependent protein kinase II (CaMKII)
is activated by calmodulin with two bound calciums
Julia M. Shifman*†‡, Mee H. Choi*§, Stefan Mihalas*, Stephen L. Mayo*†¶, and Mary B. Kennedy*¶
*Division of Biology and †Howard Hughes Medical Institute, California Institute of Technology, Pasadena, CA 91125
Contributed by Stephen L. Mayo, July 27, 2006
Changes in synaptic strength that underlie memory formation in
the CNS are initiated by pulses of Ca2 flowing through NMDA-
type glutamate receptors into postsynaptic spines. Differences in
the duration and size of the pulses determine whether a synapse
is potentiated or depressed after repetitive synaptic activity. Cal-
modulin (CaM) is a major Ca2 effector protein that binds up to four
Ca2 ions. CaM with bound Ca2 can activate at least six signaling
enzymes in the spine. In fluctuating cytosolic Ca2, a large fraction
of free CaM is bound to fewer than four Ca2 ions. Binding to
targets increases the affinity of CaM’s remaining Ca2-binding
sites. Thus, initial binding of CaM to a target may depend on the
target’s affinity for CaM with only one or two bound Ca2 ions. To
study CaM-dependent signaling in the spine, we designed mutant
CaMs that bind Ca2 only at the two N-terminal or two C-terminal
sites by using computationally designed mutations to stabilize the
inactivated Ca2-binding domains in the ‘‘closed’’ Ca2-free con-
formation. We have measured their interactions with CaMKII, a
major Ca2CaM target that mediates initiation of long-term po-
tentiation. We show that CaM with two Ca2 ions bound in its
C-terminal lobe not only binds to CaMKII with low micromolar
affinity but also partially activates kinase activity. Our results
support the idea that competition for binding of CaM with two
bound Ca2 ions may influence significantly the outcome of local
Ca2 signaling in spines and, perhaps, in other signaling pathways.
postsynaptic  protein design  synaptic plasticity  microdomains
Calmodulin (CaM) is a Ca2 effector protein comprised of twoCa2-binding lobes connected by a short linker region. Each
lobe contains two EF hands that bind Ca2 with low micromolar
affinity. CaM mediates a host of regulatory effects of Ca2 despite
the fact that the Ca2 concentration in the cytosol rarely reaches a
level expected to saturate all four Ca2-binding sites on free CaM
(1). This sensitivity is possible because association of CaM with its
targets stabilizes its Ca2-bound conformation and, therefore,
increases its affinity for Ca2 (2–4).WhenCaMwith two Ca2 ions
bound to either the N- or the C-terminal lobe associates with a
target, the affinity of the remaining lobe for Ca2 increases, often
by at least one order of magnitude, causing high positive cooper-
ativity of Ca2 binding (5). Because of this property, we predict that
when Ca2 concentrations fluctuate in the cytosol, competition
among targets for binding of CaMwill depend on their affinities for
CaM with one or two bound Ca2 and also on the magnitude of
cooperativity induced by binding to each target.
In the CNS, Ca2 influx into postsynaptic spines of excitatory
glutamatergic synapses is a key determinant of changes in synaptic
strength that underlie memory formation. The direction of the
change in strength is determined by the timing between release of
glutamate at the synapse and depolarization of the postsynaptic
membrane, caused, for example, by a back-propagating action
potential. This timing controls the duration and extent of Ca2
influx through NMDA-type glutamate receptors into the spine.
Relatively large increases of a few micromolars in Ca2 concen-
tration occurring over 2 to 3 sec induce long-term potentiation of
the synapse. In contrast, smaller changes of a few hundred nano-
molars, lasting over several seconds to 1 min, induce long-term
depression of the synapse (6–10).
How might these slight differences in Ca2 influx produce such
dramatic differences in regulation of the synapse? Ca2 that flows
into a spine through activated NMDA receptors binds to CaM and
to several other Ca2-binding proteins. Ca2 binding to CaM
enables its interaction with, and regulation of, several postsynaptic
proteins. Two prominent targets of Ca2CaM are Ca2calmod-
ulin-dependent protein kinase II (CaMKII) (11, 12) and cal-
cineurin, a protein phosphatase (13, 14). The apparent affinities of
these two proteins for Ca2CaM are quite different when mea-
sured at saturating Ca2 concentrations (200 M). CaMKII is
half maximally activated at 40–80 nM CaM (15–17), whereas
calcineurin is half maximally activated at 1–10 nM CaM (18, 19).
This severalfold difference in affinity for Ca2CaM has been
invoked to explain the different synaptic effects of high and low
Ca2 fluxes (20). However, an accurate description of the critical
initial steps of Ca2 signaling in spines requires a precise under-
standing of how different CaM targets in the spine compete for
Ca2 under conditions inwhich quantities ofCa2CaMare limited
and concentrations of Ca2 are fluctuating.
In the work reported here, we focus on understanding inter-
actions between CaM and CaMKII when the concentrations of
Ca2 or CaM are limiting. CaMKII is a dodecameric oligomer
of catalytic subunits, each of which can bind one CaM (21–23).
Binding of CaM to an individual subunit activates its kinase
activity allowing the subunit to phosphorylate other proteins. In
addition, binding of two CaMmolecules to two adjacent subunits
within a holoenzyme allows autophosphorylation of one or both
of the subunits at Thr-286 (24). This autophosphorylation ren-
ders the subunit constitutively active and it remains so until the
phosphate is removed by a protein phosphatase (25, 26). Acti-
vation and autophosphorylation of CaMKII has been shown to
be crucial for induction of long-term potentiation (27).
To measure the affinity of CaMKII for CaM with less than
four bound Ca2 ions, we designed a mutant CaM that binds
Ca2 only at N-terminal sites (CaM-NWT) and a mutant CaM
that binds Ca2 only at C-terminal sites (CaM-CWT). To closely
mimic conformations of CaM that would exist in the cytosol, we
used computationally designed mutations to stabilize the inac-
tivated Ca2-binding domains in the ‘‘closed,’’ Ca2-free con-
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formation.We found that, when saturated with Ca2, the mutant
CaMs bind to CaMKII with lowmicromolar affinity and partially
activate its kinase activity. Thus, the activity of CaMKII is more
sensitive to small increases in cytosolic Ca2 than previously
believed. The mutant CaMs described here can be used to study
the ability of CaM with two Ca2 ions bound to the C- or
N-terminal sites to associate with and activate other CaM
targets. Such studies will enable more accurate understanding of
the regulatory outcomes of local Ca2 increases in many signal-
ing pathways and cell types.
Results
Activation of CaMKII by Ca2 and CaM Is Highly Cooperative. Con-
ditions usually used to study activation of CaM targets in vitro are
necessarily different from those existing in cells. Most published
assays of activation of proteins byCaMemployCaMconcentrations
in the range of 1 M and concentrations of targets in the range of
20–50 nM. The actual concentrations of CaM and CaMKII in
spines are estimated to be in the range of 10–30 M (21, 28, 29),
whereas fluctuations in the concentration ofCa2 range over 0.1–30
Mnear open NMDA-type receptor pores (30). To better approx-
imate conditions under which competition for Ca2CaM might
occur in a spine, we measured activation and autophosphorylation
of CaMKII in reactions containing 0.28 M CaMKII (molarity of
catalytic subunits) and 12 M CaM, concentrations that are 5- to
10-fold higher than those commonly used in enzymatic assays and
yet are still practical. We observed a significant rate of autophos-
phorylation of CaMKII at as low as 350 nM Ca2 (Fig. 1A), a
concentration below the KD of even the highest-affinity Ca2-
binding sitemeasured for freeCaM(1M) (1, 31) and two orders
ofmagnitude below theKD of the lowest affinity site (20–30M).
These results suggest one or both of the following mechanisms.
First, the cooperativity of binding among Ca2, CaM, and CaMKII
might be extremely high; that is, the presence of CaMKII might
increase the apparent affinity of CaM for Ca2 by more than one
order of magnitude. Second, CaMmight not require occupation of
all its high-affinity Ca2-binding sites to initiate autophosphoryla-
tion of CaMKII.
The magnitude of the increase in affinity of CaM for Ca2 when
CaM binds to CaMKII has not been measured previously under
conditions approximating those in spines. We therefore compared
the affinity of free CaM for Ca2 to that of CaM in the presence
of CaMKII and in the presence of a peptide having the sequence
of the CaM-binding domain of CaMKII (CaMKII-cbp), at concen-
trations of 5 M for each protein (Fig. 1B). We found that the
concentrations of Ca2 at which half of the Ca2-binding sites on
CaM are occupied are 15 M for free CaM, 3–4 M in the
presence of CaMKII, and 1–2 M in the presence of CaMKII-
cbp. These data show that the presence of CaMKII increases the
affinity of CaM for Ca2 5-fold under conditions approximating
those in a postsynaptic spine. This effect undoubtedly contributes
to the ability of Ca2 concentrations1 M to activate CaMKII in
our experiments; however, it is not high enough to account for it
completely.
Computationally Designed Mutant CaMs That Bind Two Ca2 ions at
Either the C-Terminal or the N-Terminal Sites. One traditional view
held that occupation of all four Ca2-binding sites on CaM is
required to change the activity ofmost targets and, perhaps, also for
high-affinity binding of CaM to targets. Discoveries of alternative
modes of regulation by CaM, including some involving CaM with
Ca2 bound to only one of its two lobes, indicate thatCaM is, in fact,
more versatile in its regulatory mechanisms (32). CaM consists of
N- and a C-terminal globular helical domains connected by a
central flexible helix (Fig. 2 A and B). Each globular domain
contains two Ca2-binding sites of the EF-hand variety. The
C-terminal sites have6-fold higher intrinsic affinity for Ca2 than
the N-terminal sites (31, 36); however, the on rate for Ca2 binding
to the N-terminal sites is 10-fold faster. In the absence of Ca2,
Fig. 1. Cooperative binding of Ca2 to CaM in the presence of CaMKII. (A)
Autophosphorylation of CaMKII in the presence of WT CaM at varying Ca2
concentrations. Reactions were performed for 1 min, as described inMethods,
with 10 M CaM, 0.28 M CaMKII, and the indicated Ca2 concentrations.
Autophosphorylation was detected by immunoblotting with the phos-
phosite-specific antibody 22B1, as described in Methods. The position of the
-subunit of CaMKII is indicated. Note that the band shifts to slightly slower
mobility as a second site, Thr-305, becomes autophosphorylated. (B) Increase
in affinity of Ca2 for CaM in the presence of CaMKII or CaMKII-cbp. Ca2
binding to 5 M CaM was measured in a competition assay with a fluorescent
Ca2-binding dye, Fluo4FF at 25°C. Ca2was titrated into solutions containing
5 M Fluo4FF and WT CaM alone (Œ), or in the presence of 5 M CaMKII (■),
or 5 M CaMKII-cbp (}). The data were fit with equations for Ca2 binding at
equilibrium to CaM alone or to CaM in the presence of CaMKII or CaMKII-cbp
as described in Methods.
Fig. 2. Conformations of WT CaM and the designed mutant CaMs. (A) NMR
structure of Ca2-free CaM (PDB ID code 1CFD) (33). (B) X-ray crystal structure
of Ca2-bound CaM (PDB ID code 3CLN) (34). The hydrophobic patches im-
portant for target recognition are shown in red. Ca2 atoms are shown as
yellow spheres. (C) X-ray crystal structure of Ca2CaM bound to CaMKII-cbp,
shown in pink (PDB ID code 1CM1) (35). (D and E) Models of the mutant CaMs
designed to bind Ca2 only in the C-terminal domain, CaM-CWT (D), and only
in the N-terminal domain, CaM-NWT (E). These models were generated by
combining the structure of the WT Ca2CaM domain with the structure of
Ca2-free CaM representing the mutated CaM domain. Mutant residues pre-
dicted by the computation to produce the best stabilized structure (Table 1)
are shown in red. The figure was generated with PyMOL (DeLano Scientific,
South San Francisco, CA).
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CaMadopts a closed conformation (33, 37, 38) inwhich it is not able
to interact with most of its targets (Fig. 2A). Binding of Ca2 to
CaM causes a reorientation of helices inside the globular domains
and a consequent exposure of patches of hydrophobic residues
important for target recognition (34) (Fig. 2B). A shift toward this
‘‘open’’ CaM conformation is believed to be a prerequisite for
interactions with many CaM-regulated proteins (1, 32, 39). Binding
to most targets, including the CaM-binding domain of CaMKII
(CaMKII-cbp), induces a conformation in which CaM wraps
around the target domain, resulting in a coil-to-helix transition in
the target (35, 40) (Fig. 2C).
To test whether binding of Ca2 to both the C-terminal and the
N-terminal lobes of CaM is necessary for activation of CaMKII
under conditions that approximate those in the spine, we designed
mutant CaMs that bind Ca2 only in the C- or N-terminal lobes:
CaM-CWT and CaM-NWT, respectively (Fig. 2 D and E and Table
1). Unlike previously reported mutant CaMs that are deficient in
Ca2 binding because of point mutations of Ca2-ligating residues
(36, 41, 42), ourmutant CaMswere designed tomimic intermediate
conformations that CaM might adopt in the cytosol by specifically
stabilizing the closed conformation of the mutant Ca2-binding
loops. We used the protein design program ORBIT (43), which
employs an empirical atom-based force field and a fast side-chain
selection algorithm to search through different protein sequences to
find the lowest energy sequence for a given protein structure. To
abolish Ca2 binding to a particular CaM domain, we redesigned
the amino acid sequence of either the N-terminal or the C-terminal
domain, leaving the other domain intact. For each calculation, a
sequence of CaM residues forming the mutant Ca2-binding site in
the N- or C-terminal domain was optimized by using the Ca2-free
CaM structure as the template (ref. 33; Table 1). For each of these
calculated sequences, we verified that the redesigned Ca2 site had
fewer residues with Ca2 coordinating side chains.
Assessment of Folding and Ca2 Binding byMutant CaMs.The designed
mutant CaMs were expressed in Escherichia coli and assessed by
far-UV circular dichroism for proper folding and Ca2 binding.
In the absence of Ca2, both mutant CaMs retain a predomi-
nantly -helical structure essentially identical to that of WT
CaM. Upon addition of Ca2, both exhibit a small change in the
circular dichroism signal, as does WT CaM, reflecting Ca2-
induced rearrangements of the EF-hand domains (Fig. 6, which
is published as supporting information on the PNAS web site).
Binding of Ca2 to the C-terminal sites has been shown to be
responsible for most of these changes in circular dichroism
spectrum (44). Consistent with that finding, the structural tran-
sition of our N-terminal mutant (CaM-CWT) is nearly identical
to that of WT CaM (Fig. 6 A and B).
We compared theCa2 binding stoichiometry ofWTandmutant
CaMs by electrospray mass spectrometry as described in ref. 45. In
the presence of EGTA, the spectra of WT CaM and mutant CaMs
contained a major peak corresponding to the molecular weight of
the protein in the Ca2-free state (data not shown). In the presence
of saturating Ca2, the WT CaM spectrum comprised a peak
corresponding to Ca2-free CaM and four additional peaks reflect-
ing incremental additions of one Ca2 ion. The major peak corre-
sponds to four bound Ca2 ions (Fig. 3A). For CaM-CWT and
CaM-NWT, themajor peaks correspond to one and two boundCa2
ions, as expected (Fig. 3 B and C).
We measured the Ca2-binding affinities of the mutant CaMs
employing the fluorescent calcium sensor Fluo4FF. When CaM
competes with Fluo4FF for available Ca2, the fluorescence signal
is reduced (Fig. 3D). The concentrations of Ca2 and CaM over
which the competition occurs reflect the affinity of CaM for Ca2.
The competition curves were fit with a fourCa2 sitemodel forWT
CaM and a two Ca2 site model for the mutant CaMs (46).
Ca2-binding affinities of WT and mutant CaMs range from 1 to
Table 1. Computationally designed N- and C-terminal mutant CaMs
CaMs
Designed positions
Site 1 Site 2 Site 3 Site 4
20 22 24 27 31 56 58 60 62 67 93 95 97 100 104 129 131 133 135 140
CaM WT D D D I E D D N T E D D N I E D D D Q E
CaM-CWT T K Q I E S D E I K – – – – – – – – – –
CaM-NWT – – – – – – – – – – A R D M E R D N E N
All CaM residues that directly coordinate Ca2 ions with their side chains (positions 20, 22, 24, 31, 56, 58, 60,
and 67 for the N-terminal domain and 93, 95, 97, 104, 129, 131, 133, and 140 for the C-terminal domain) were
included in the optimization. Residues 62 and 135 also were included because they coordinate Ca2 ions with their
backbone carbonyls. Residues 27 and 100, which do not coordinate Ca2 ions, but are in close proximity to the ion
and help define the Ca2-binding loop, also were optimized. Bold lettering shows mutations with respect to the
WT CaM sequence. –, positions were not included in the calculation for the mutant CaM indicated.
Fig. 3. High-affinity Ca2-binding sites on WT and mutant CaMs. (A–C)
Stoichiometry of Ca2 binding to WT and mutant CaMs measured by electro-
spray mass spectrometry at 10 M CaM and 200 M Ca2. (A) WT CaM. (B)
CaM-CWT. (C) CaM-NWT. (D) Ca2 binding to WT and mutant CaMs measured in
a competition assay with the fluorescent Ca2-binding dye, Fluo4FF. Ca2was
titrated into a solution of Fluo4FF (10 M) alone (F), Fluo4FF plus 10 M
CaM-CWT (ƒ),10M CaM-NWT (Œ), or 10M WT CaM (■). The data were fit with
a model assuming four high-affinity Ca2-binding sites for WT CaM, two for
CaM-CWT and CaM-NWT, and a single Ca2-binding site for Fluo4FF (Table 2).
13970  www.pnas.orgcgidoi10.1073pnas.0606433103 Shifman et al.
40M(Table 2) and are in approximate agreement with previously
published values for WT CaM (1, 36). The data reveal positive
cooperativity between the two neighboring Ca2-binding sites in
bothmutantCaMs, as has been reported forWTCaM(1, 31). Thus,
by several criteria, the two mutants behave as desired. In the
presence of a saturating concentration of Ca2, CaM-CWT binds
twoCa2 ions in the C-terminal lobe, whereas CaM-NWT binds two
Ca2 ions in the N-terminal lobe.
We compared binding of WT and mutant CaMs to CaMKII-
cbp at a saturating Ca2 concentration by using circular dichro-
ism to measure the coil-to-helix transition in the peptide upon
binding, as previously described (ref. 48; Fig. 7, which is pub-
lished as supporting information on the PNAS web site). Dis-
sociation constants calculated by fitting the data to a 1:1 binding
model show that WT CaM binds to CaMKII-cbp with a KD of 5
nM, similar to values reported for other CaM-binding peptide
sequences (48). In contrast, CaM-CWT binds with a KD of 70 nM,
and CaM-NWT binds with a much lower affinity KD of 6 M.
Activation of CaMKII by Mutant CaMs.We testedwhether themutant
CaMs support activation of CaMKII by measuring their ability to
activate autophosphorylation at Thr-286. Unexpectedly, we found
that, at saturating Ca2 concentration, either of the mutant CaMs
(10 M) supports substantial autophosphorylation of CaMKII in a
1-min reaction (Fig. 4A). This result means that CaM does not
requireCa2 bound to both of its lobes to activateCaMKII. TheKact
values for CaM-CWT and CaM-NWT under these conditions were 5
and 20 M, respectively (Fig. 4B), compared with a Kact value of
50 nM for WT CaM with four bound Ca2 (Table 2). These
results are consistent with the higher affinity of CaM-CWT for
CaMKII-cbp and indicate that the binding of 2 Ca2 ions to the
C-terminal lobe of WT CaM results in more effective activation of
CaMKII than binding of two Ca2 ions to the N-terminal lobe.
To explore the ability of the mutant CaMs to activate CaMKII
under conditions closer to those believed to exist in postsynaptic
spines during synaptic activity, we measured autophosphorylation
of CaMKII while varying Ca2 concentration from 0 to 10 M in
the presence of 5MCaM.Autophosphorylation ofCaMKII in the
presence of CaM-CWT was first detectable at 1 M Ca2 and in
the presence of CaM-NWT at 5 M Ca2 (Fig. 4C). The rate of
autophosphorylationwas half-maximal at 2MCa2 forWTCaM,
at 6 MCa2 for CaM-CWT, and at32 MCa2 for CaM-NWT.
We then measured activation of CaMKII by each mutant CaM
while varying their concentrations from 0.5 to 20 M in 12 M
Ca2. Under these conditions, WT CaM had a Kact of 0.4 M,
CaM-CWT7M, andCaM-NWT30M(Fig. 4D). These results
show that, in the presence of Ca2, both CaM-CWT, which mimics
WT CaM with two Ca2 ions bound at its C terminus (CaM2C),
and CaM-NWT, which mimics WT CaM with two Ca2 ions bound
at the N terminus (CaM2N), can bind to and partially activate
CaMKII in vitro under conditions, approximating those in stimu-
lated postsynaptic spines. The results suggest that CaM2C is far
more effective than CaM2N at binding and activating CaMKII in
low concentrations of Ca2.
We performed quench flow experiments to measure the turn-
over rates of autophosphorylation supported by WT and mutant
CaMs at their saturating concentrations. The turnover rate sup-
ported by either mutant was10% of that supported by WT CaM
(Table 2 and Fig. 5), suggesting that binding of the mutant CaMs
cannot produce the optimal conformational change required for a
maximal rate of autophosphorylation. We conclude that both
mutant CaMs support activation and autophosphorylation of
CaMKII; however, their affinity for CaMKII is lower than that of
WT CaM, and they support a lower enzymatic turnover number.
Discussion
We used a computational method to design mutant CaM proteins
that bind two Ca2 ions at either the N- or C terminus. At the
inactivated terminus, we designed mutations that stabilize the
closed structure of the Ca2-binding loop favored when Ca2 is not
bound (33, 37, 38). We used these mutants to study how CaM with
Ca2 bound to only one of its two lobes (CaM2C or CaM2N)
interacts with its target protein CaMKII. These interactions are of
interest because the direction of the changes in synaptic strength
that occur during storage of information in neural circuits is
exquisitely sensitive to small changes in the concentration of
postsynaptic Ca2 that occur during repetitive electrical activity (6,
8). This sensitivity to Ca2 occurs at concentrations at which the
equilibrium concentration of CaM2C (reached in50 msec) is the
same or higher than the concentration of WT CaM with Ca2 ions
Table 2. Kinetic properties of WT and mutant CaMs
CaMs
KD values for Ca2, M
Kact for
CaMKII, M2
kp of CaMKII,
(sec1)3KD1 KD2 KD3 KD4
WT CaM 7.9 1.7 35 8.9 0.04 0.96
CaM-CWT 25 1.6 – – 5 0.064
CaM-NWT 28 3.3 – – 20 0.12
KD values for Ca2 were calculated as described in Methods from the data
in Fig. 3Dwith the CaLigator program (47) downloaded from www.bpc.lu.se
researchcaligator. A model containing four Ca2 sites was used for WT CaM,
and one containing two Ca2 sites was used for CaM-CWT and CaM-NWT. The
concentration of WT CaM required for half-maximal rate of CaMKII autophos-
phorylation, Kact, is taken from Meyer et al. (16). Kact values for mutant CaMs
were determined from the data in Fig. 4B. The intrinsic turnover rate of CaMKII
autophosphorylation, kp, was determined from data in Fig. 5. Confidence
intervals (95%) for kp values were 0.67–1.25 for WT CaM, 0.044–0.084 for
CaM-CWT, and 0.079–0.16 for CaM-NWT.
Fig. 4. Activation of autophosphorylation of CaMKII by WT and mutant
CaMs. (A) Reactions were performed with 10 M CaM and 0.28 M CaMKII
subunits for 1 min in the absence () or presence () of 300 M Ca2, as
described in Methods. The positions of  and  subunits of CaMKII are
indicated. (B) Dependence of autophosphorylation on the concentration of
mutant CaMs. Autophosphorylation was performed as in A, except reactions
were performed for 30 sec. To determine the Kact values reported in Table 2,
the data were normalized to the level of autophosphorylation in saturating
Ca2CaM for 1 min and fit with a model assuming binding of 1 CaM to 1
catalytic subunit. (C) Dependence of autophosphorylation on Ca2 in the
presence of WT and mutant CaMs. Reactions were performed as in A, except
with 5 M CaM, and quantified as in B. (D) Dependence of autophosphory-
lation on CaM concentration in the presence of WT and mutant CaMs. Reac-
tions were performed as in A, except with 12 M Ca2, and quantified as in B.
Mean  SD of four experiments. WT (), CaM-CWT (F), and CaM-NWT (■).
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bound at all four sites (CaM4), as determined by simulations of
Ca2 binding to free CaM under conditions present in spines (ref.
49 and unpublished observations). Furthermore, because the N-
terminal lobe of CaM binds Ca2 with10- to 100-fold higher kon
and koff than the C-terminal lobe, as much as 20% of free CaMmay
be in the CaM2N conformation 5 msec after the onset of Ca2
influx through NMDA receptors. Thus, competition for CaM2C or
CaM2Nwithin a synaptic spinemay determinewhether the synapse
will be potentiated or depressed.
Using the values reported in this study we can estimate the
relative concentrations of CaM2C bound to CaMKII
(CaM2CCaMKII), CaM2NCaMKII, and CaM4CaMKII when
the Ca2 concentration in the postsynaptic density is 0.5 M or 2
M Ca2 (S.M. and M.B.K., unpublished data). We assumed
concentrations of 30 M CaMKII subunits and 10 M free CaM
and a KD of 50 nM for binding of CaM4 to CaMKII. At 0.5 M
Ca2, the concentration of CaM2CCaMKII is 0.8 M, which is
10 timesmore than the concentration of CaM4CaMKII. Because
of the low affinity of CaM2N for CaMKII, its concentration is80
times lower than the concentration of CaM2CCaMKII. At 2 M
Ca2, the concentrations of CaM2CCaMKII (2.3 M) and
CaM4CaMKII (3.2 M) are roughly equal; both still exceed
CaM2NCaMKII by a factor of 80. These numbers show that the
enhanced affinity for the third and fourth Ca2 ions bound to CaM
when CaMKII is present results in formation of a significant
amount of CaM4CaMKII at 2MCa2. However, thismechanism
doesn’t appear to account quantitatively for the substantial activa-
tion of autophosphorylation at concentrations of Ca2 as low as
0.35 M (Fig. 1). We conclude that activation of CaMKII by
binding of CaM2C alone likely contributes to activation of CaMKII
during small increases in Ca2 in the spine above the basal
concentration of 80 nM such as might occur during low-frequency
stimulation. This finding is consistent with the recently reported
structural arrangement of the holoenzyme of CaMKII (22) (see
Supporting Text and Fig. 8, which are published as supporting
information on the PNAS web site). Our findings demonstrate the
importance of understanding the kinetics of interactions of CaM2C
and CaM2N with their various targets to correctly simulate the
orchestration of biochemical responses to Ca2 influx into the
spine.
Previous studies have shown that the individual N- or C-terminal
lobes of CaM with bound Ca2 can activate certain effector
proteins, phosphorylase kinase (50), myosin light chain kinase,
neuronal nitric oxide synthase (51), and adenylate cyclase (52).
These studies relied either on isolated N-terminal and C-terminal
fragments of CaM generated by proteolysis (50, 51) or on point
mutants of CaM that have lost one or more Ca2-binding sites (52).
More recent studies have made use of CaM with single-point
mutations in each of the two N-terminal sites (CaM12) or the two
C-terminal sites (CaM34) to show that the individual lobes of CaM
have distinct functional effects on voltage-activated Ca2 channels
(53, 54). Although these mutants have been useful for understand-
ing the qualitative ability of individual CaM domains to interact
with target proteins, they are not ideal for determining the actual
binding constants of such interactions as they occur in vivo. The
reason that single-point mutations or proteolytic fragmentation
may introduce structural changes in CaM that do not represent its
intermediate conformations in the cytosol. These changes may
influence their rates of binding to targets (55). By stabilizing the
mutated Ca2-binding loops of CaM in the structure assumed by
apo-CaM, we have attempted to mimic as closely as possible the
transient forms of CaM loaded with Ca2 ions at either the N or C
terminus. Thesemutant CaMswill be useful for understanding how
Ca2 controls mechanisms of synaptic plasticity that underlie
learning and memory. They also may be useful for studying
Ca2-signaling events in other cell types.
Methods
Computational Methods. The sequences for the mutant CaMs were
designed by using the protein design program ORBIT (ref. 43; see
Supporting Text). The sequences of the N- and C-terminal CaM
domains were optimized with the Ca2-free CaM structure as a
template (33) to produce CaM-CWT and CaM-NWT, respectively.
Expression of CaM Proteins. cDNAs encoding CaM-CWT and CaM-
NWT mutants were constructed with an inverse PCR procedure
beginning with theWTCaM cDNA cloned into pET-15 (Novagen,
San Diego, CA). WT and mutant CaMs were expressed and
purified as described in ref. 56.
Peptide Synthesis. The CaMKII-cbp peptide corresponding to the
CaM-binding domain of CaMKII (sequence -AKSKWKQAFNA-
TAVVRHMRKLQ-) was synthesized and purified in the Caltech
Peptide Synthesis Facility as described in ref. 56.
Electrospray Mass Spectrometry. Electrospray ionization mass spec-
trometry was performed on an API365 LCMSMS system (PE
SCIEX) with a nanospray ion source (Protana, Toronto, ON,
Canada) operated at an infusion mode of 0.2 lmin and a spray
voltage of 1.4 kV. The data were collected in the negative ion
mode. The Ca2-bound samples (10 MCaM) were diluted into 4
mM NH4HCO3200 M CaCH3CO215% CH3OH, pH 8.0. For
the Ca2-free samples, CaCH3CO2 was replaced with 500 M
EGTA.
Ca2-Binding Affinities. Ca2 binding to WT and mutant CaMs was
measured by competition with the Ca2-binding fluorescent dye
Fluo4FF (Molecular Probes, Eugene, OR). We determined the
intrinsic binding affinity of Fluo4FF for Ca2 (KD 13 M) in the
absence of CaM by titrating concentrated CaCl2 into a 10 M
solution of Fluo4FF in 50 mM Tris100 mM NaCl1 mM MgCl2,
pH 7.2 at 25°C and recording fluorescence after addition of each
aliquot of Ca2 on a Hitachi (Tokyo, Japan) F-4500 fluorescence
spectrophotometer (excitation at 488 nm and emission recorded at
516 nm). The measured fluorescence signal F was used to calculate
the free Ca2 concentration [Ca2]free, the concentration of Ca2
bound to the dye [Ca2Dye], and the affinity of CaM for Ca2 in
the presence of targets as described in Supporting Text.
Fig. 5. Determination of turnover number for autophosphorylation of
CaMKII in the presence of WT and mutant CaMs. The time course of auto-
phosphorylation of CaMKII was determined in saturating Ca2CaM. Data
were gathered with a Quench Flow apparatus and normalized as described in
Methods, then fit with the equation:A(1ekp(t t0)), wherekp is the turnover
rate (unknown), t0 (a negative term) is the time at which the extrapolated
autophosphorylation curve crosses the x axis (Supporting Text), and A is a
scaling factor. A, kp, and t0 were fit simultaneously by nonlinear regression
performed with the Levenberg–Marquardt method in Mathematica. The kp
values supported by each form of CaM are summarized in Table 2. Data were
obtained from five experiments with WT CaM, five with CaM-CWT, and three
with CaM-NWT. WT CaM (F), CaM-CWT (ƒ), and CaM-NWT (Œ).
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CaMKII Autophosphorylation Assay. Reactions were initiated by
addition of purified CaMKII (0.28 M) to a final volume of 100 l
of 50 mM Tris0.1 M NaCl20.9 mg/ml BSA50 M ATP5 mM
DTE, pH7.2, the desired concentration ofWTormutantCaM, and
desired Ca2 concentration determined by mixing appropriate
ratios of 100 mM CaCl2 and 100 mM EGTA as described in
instructions supplied with the Ca2 buffer kit (Molecular Probes,
Carlsbad, CA). The buffer was warmed to 30°C for 1 min, reactions
were initiated, proceeded for 1 min, and were stopped by the
addition of 3% SDS2% 2-mercaptoethanol. Samples containing
0.2g of CaMKII were fractionated by SDSPAGE, transferred by
electrophoresis onto a nitrocellulose membrane for 1 h at 350 mA
in 25mMTris base0.2Mglycine20%methanol.Membraneswere
immunoblotted with 7.5 g antibody 22B1 in 15 ml of 50 mM Tris,
pH 7.40.5MNaCl0.05%Tween 20 (TTBS) plus 2% normal goat
serum for 3 h at 4°C. Monoclonal antibody 22B1 (anti-phospho-
CaMKII; Affinity Bioreagents, Golden, CO) is specific for  and 
subunits of CaMKII only when they are phosphorylated at Thr-
286287 (in ). Bound antibodies were visualized by measuring
fluorescence of a secondary antibody, (IRDye800-Anti-mouse;
Rockland, Gilbertsville, PA; 1.5 g in 30 ml of TTBS) with an
Odyssey Imaging System (Li-Cor Biosciences, Lincoln, NE). Con-
ditions were adjusted so that fluorescence intensity was linear over
the range of CaMKII measured. The amount of autophosphory-
lated CaMKII was calculated by quantifying the intensity of each
band with the Odyssey software and normalizing it to the intensity
of a band corresponding to standard fully autophosphorylated
CaMKII prepared by incubating in the assay solution for 1min with
300 M Ca2 and 10 M WT CaM.
Measurement of Turnover Numbers for Autophosphorylation of
CaMKII. Initial rates of autophosphorylation were measured at
saturating levels of Ca2CaM and ATP with the use of a temper-
ature-controlled Kintek Model RQF-3 Quench Flow apparatus
(Kintek Corp., Austin, TX). Reactions were initiated at 100ms, 300
ms, 1, 3, 10, and 30 sec by rapid mixing of solution 1 (25 mM
TrisHCl, pH 7.20.1MNaCl1mMMgCl22mMCa20.9mg/ml
BSA5mMDTE1.4MCaMKII catalytic subunits, and either 12
M WT CaM, 30 M CaM-CWT, or 60 M CaM-NWT) and
solution 2 (identical to solution 1 except that CaMKII and CaM
were replaced by 200MATP). The two solutions were kept at 4°C
until they were transferred to the quench flow apparatus and
warmed for 1 min to 30°C. Autophosphorylation was initiated by
rapid mixing of 16 l of each solution and terminated by rapid
addition of a final concentration of 1% SDS, 3.3 mM glycineHCl,
pH 2.9 (see Supporting Text) After quenching, all reactions were
brought to a final concentration of 3% SDS, 66 mM TrisHCl (pH
7.2)2% 2-mercaptoethaol5% glycerol40 g/ml Bromophenol
Blue and subjected to SDSPAGE followed by immunoblotting
with antibody 22B1 as described for the autophosphorylation assay.
Intensities of autophosphorylated bands were quantified with the
Odyssey Imaging System. The levels of autophosphorylation were
normalized to that of fully autophosphorylated CaMKII incubated
in the assay for 30 sec (WT CaM) or 100 sec (mutant CaMs). The
amount of autophosphorylated CaMKII in each sample lane was
obtained from a standard curve built for each set of experiments by
measuring the intensity of 0.06, 0.12, and 0.23 g of fully autophos-
phorylated CaMKII and fitting the standard data with a power
function.
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